News Detail

Entero Therapeutics Inc expected to post a loss of $1.55 a share - Earnings Preview

Reuters · 09/06 20:20

Listen to the news

Entero Therapeutics Inc <ENTO.OQ> expected to post a loss of $1.55 a share - Earnings Preview

Entero Therapeutics Inc ENTO.OQ ENTO.O is expected to show change in quarterly revenue when it reports results on September 9 (estimated) for the period ending June 30 2024
LSEG's mean analyst estimate for Entero Therapeutics Inc is for a loss of $1.55 per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Entero Therapeutics Inc is $36.00, above its last closing price of $0.40.

This summary was machine generated September 6 at 20:20 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.

What's Trending

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.